For patients taking generic antibiotics, adequate potency levels can mean the difference between a quick recovery and a […]

For about two months, Alexion has been exploring whether its Soliris—used to treat several rare diseases—might hold promise in treating […]

As a partner with Novartis on JAK inhibitor Jakafi, Incyte has pinned its future fortunes on the success […]

As the U.S. economic toll from COVID-19 lockdowns continue to mount—with tens of millions out of work and businesses suffering—discussion has […]

As an ex-army surgeon and a military historian, we have previously felt uneasy about healthcare workers being described […]

Incyte’s Pemazyre can now be used to treat the bile duct cancer. The firm has also launched a […]

The agency concluded that the risks of the medicine outweigh its benefits

Frontline workers now eligible for testing will include the police, the fire service, frontline benefits workers and those […]

Study aiming to enrol 3,000 patients via more than 100 GP surgeries

The data is being used by researchers to evaluate the effectiveness of a number of potential treatments